Macroencapsulated Human iPSC-Derived Pancreatic Progenitors Protect against STZ-Induced Hyperglycemia in Mice

In type 1 diabetes, a renewable source of human pancreatic β cells, in particular from human induced pluripotent stem cell (hiPSC) origin, would greatly benefit cell therapy. Earlier work showed that pancreatic progenitors differentiated from human embryonic stem cells in vitro can further mature to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cell Reports
Autors principals: Haller, Corinne, Piccand, Julie, De Franceschi, Filippo, Ohi, Yuki, Bhoumik, Anindita, Boss, Christophe, De Marchi, Umberto, Jacot, Guillaume, Metairon, Sylviane, Descombes, Patrick, Wiederkehr, Andreas, Palini, Alessio, Bouche, Nicolas, Steiner, Pascal, Kelly, Olivia G., R.-C. Kraus, Marine
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6449839/
https://ncbi.nlm.nih.gov/pubmed/30853374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stemcr.2019.02.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars